Hakutulokset - Ming‐Shyang Huang

  • Näytetään 1 - 3 yhteensä 3 tuloksesta
Tarkenna hakua
  1. 1
    Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells

    Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells Tekijä An-Fu Lee, Man‐Chin Chen, Chao‐Ju Chen, Chih‐Jen Yang, Ming‐Shyang Huang, Yu‐Peng Liu

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    <scp>PCAF</scp>‐mediated acetylation of <scp>ISX</scp> recruits <scp>BRD</scp>4 to promote epithelial‐mesenchymal transition

    <scp>PCAF</scp>‐mediated acetylation of <scp>ISX</scp> recruits <scp>BRD</scp>4 to promote epithelial‐mesenchymal transition Tekijä Li‐Ting Wang, Kwei‐Yan Liu, W.Y. Jeng, Cheng‐Ming Chiang, Chee‐Yin Chai, Shyh‐Shin Chiou, Ming‐Shyang Huang, Kazunari K. Yokoyama, Shen‐Nien Wang, Shau‐Ku Huang, Shih‐Hsien Hsu

    Julkaistu 2020
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients Without Optimally Controlled asthma (REACT) Study [Corrigendum]

    Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients... Tekijä Shih-Lung Cheng, Ming-Lin Ho, Yun-Fa Lai, Hao‐Chien Wang, Jeng‐Yuan Hsu, Shih‐Feng Liu, Ming-Shyang Huang, Cheng-Hung Lee, Ching‐Hsiung Lin, Liang‐Wen Hang, Yu‐Chih Liu, Kuang‐Yao Yang, Jia-Horng Wang

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Errata/Corrigenda
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: